Literature DB >> 19546611

Castleman disease: an update on classification and the spectrum of associated lesions.

Danielle M P Cronin1, Roger A Warnke.   

Abstract

Since its initial description, researchers have expanded the spectrum of Castleman disease to include not only the classic and well-recognized hyaline-vascular type, but also the plasma cell type and multicentric types of broader histologic range, including human herpes virus-8-associated Castleman disease. These less common subtypes of Castleman disease are less familiar, and may be under-recognized. Also of practical importance, current authors are restructuring the classification of multicentric Castleman disease to accommodate the emerging pathogenic role of human herpes virus-8 and its association with the recently described plasmablastic variant. In addition to an increased risk of lymphoma, patients with Castleman disease also are at increased risk for other related neoplasms, including Kaposi sarcoma and follicular dendritic cell tumors, which are of prognostic and therapeutic relevance. This review focuses on the histologic diagnosis of Castleman disease, current and emerging concepts in its pathogenesis and classification, and associated histopathologic entities.

Entities:  

Mesh:

Year:  2009        PMID: 19546611     DOI: 10.1097/PAP.0b013e3181a9d4d3

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  93 in total

Review 1.  Video assisted thoracoscopic resection of a posterior mediastinal Castleman's tumor.

Authors:  Shohan Shetty; Robert A Brenes; Lucian Panait; Juan A Sanchez
Journal:  J Cardiothorac Surg       Date:  2011-09-20       Impact factor: 1.637

2.  Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.

Authors:  Deboeeta Chatterjee; Bala Chandran; Edward A Berger
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma.

Authors:  Lan Li; Yong-Hong Shi; Zhi-Juan Guo; Tian Qiu; Lei Guo; Hong-Ying Yang; Xun Zhang; Xin-Ming Zhao; Qin Su
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

4.  Castleman's disease presenting in the lungs: A report of two cases.

Authors:  Weijun Cao; Shuo Liang; Jinming Liu; Jiuwu Bai; Huiping Li
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

5.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Thomas S Uldrick; Adam Bagg; Dale Frank; David Wu; Gordan Srkalovic; David Simpson; Amy Y Liu; David Menke; Shanmuganathan Chandrakasan; Mary Jo Lechowicz; Raymond S M Wong; Sheila Pierson; Michele Paessler; Jean-François Rossi; Makoto Ide; Jason Ruth; Michael Croglio; Alexander Suarez; Vera Krymskaya; Amy Chadburn; Gisele Colleoni; Sunita Nasta; Raj Jayanthan; Christopher S Nabel; Corey Casper; Angela Dispenzieri; Alexander Fosså; Dermot Kelleher; Razelle Kurzrock; Peter Voorhees; Ahmet Dogan; Kazuyuki Yoshizaki; Frits van Rhee; Eric Oksenhendler; Elaine S Jaffe; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

6.  Castleman's disease of the spleen.

Authors:  Hee-Jeong Lee; Ho-Jong Jeon; Sang-Gon Park; Chi-Young Park
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

7.  Multicentric Castleman's disease and HIV.

Authors:  John R Krause; Sara D Robinson; Estil A Vance
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-01

8.  Surgical Management of Unicentric Castleman's Disease in the Abdomen.

Authors:  Min-Sang Kim; Jae-Kyun Ju; Young Kim
Journal:  Ann Coloproctol       Date:  2014-04-25

9.  Castleman's disease presenting as a pleural tumor: a case report with CT findings.

Authors:  Kyung Won Doo; Bomi Kim
Journal:  Radiol Case Rep       Date:  2017-11-01

Review 10.  Biologic Agents in the Treatment of Multicentric Castleman Disease.

Authors:  Konstantinos Kapriniotis; Savvas Lampridis; Sofoklis Mitsos; Davide Patrini; David R Lawrence; Nikolaos Panagiotopoulos
Journal:  Turk Thorac J       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.